Action of Amantadine on Post-Stroke Aphasic Patients

• Status: Completed
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of the study is to test the action of the amantadine, as DOPA-agonist, in a double blind cross-over trial, amantadine / placebo, on the verbal fluency of chronic post stroke aphasic patients.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier Universitaire de Nice
• Treatments: Amantadine

Criteria

Inclusion Criteria:

• RANKIN < 3

• > 18 years and < 75

• francophone

• within cognitive deficit known before stroke

• stroke, single in sylvian artery area

• aphasia " non fluent " following a stroke

• stroke > six month

• stable treatment

Exclusion Criteria:

• RANKIN > 3

• non francophone

• do not read nor write

• many stroke - against indication

• participated in another clinical trial

• deaf or blind

• intercurrent disease

• new treatment (< 2 months) cognitive

• pregnant or lactating